KRT4 antibody (AA 181-292)
Quick Overview for KRT4 antibody (AA 181-292) (ABIN7871455)
Target
See all KRT4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 181-292
-
Purpose
- Cytokeratin 4 Antibody / KRT4
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 181-292) was used as the immunogen for this Cytokeratin 4 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the Cytokeratin 4 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Cytokeratin 4 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- KRT4 (Keratin 4 (KRT4))
-
Alternative Name
- Cytokeratin 4
-
Background
- Cytokeratin 4 (KRT4) is an intermediate filament protein associated with Cytokeratin 13 (KRT13). It is expressed in suprabasal cells of non-keratinized stratified squamous epithelium of esophagus, cornea, anus, larynx, pharynx and tongue. Decreased expression of KRT4 is associated with head and neck squamous carcinoma. It is helpful in differentiation of squamous cell carcinoma of esophagus origin from that of thyroid origin.
-
UniProt
- P19013
Target
-